Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07283497 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Itraconazole Therapy In Bronchiectasis With Airway Mold

Name: Itraconazole Therapy In Bronchiectasis With Airway Mold — clinical trial record (NCT07283497)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 4

SponsorMayo Clinic

Started2026-08-17

View on ClinicalTrials.gov ↗

Amendment history

2026-08-20

Study Status v3

Start dateestimated 2026-06-20→confirmed 2026-08-17

2026-05-27

Study Status v2

Start date2026-03-15→2026-06-20

2026-02-08

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Start date2025-12-15→2026-03-15

Study sitesdetails revised at 1 of 1 site

2025-12-12

Original filing

Mayo Clinic

1,015 trials monitored

See 115 trials at risk

The primary objective of this study is to evaluate the feasibility of itraconazole therapy in patients with bronchiectasis and airway mold. Feasibility will be assessed through recruitment success, treatment adherence, tolerability, and participant retention. The study will also explore the impact on respiratory symptoms and airway microbiome diversity.

Trial Details

NCT Number	NCT07283497
Lead Sponsor	Mayo Clinic
Conditions	Bronchiectasis, Fungal Infection of Upper Respiratory Tract
Enrollment	30 participants
Start Date	2026-08-17
Primary Completion	2030-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-21